FDA rule would give opening to generic drug plaintiffs

Related posts:

1. FDA rule would give opening to generic drug plaintiffs  WASHINGTON – Following two U.S. Supreme Court decisions that shut the door on state-law failure-to-warn and design-defect claims over generic...
2. Generic drug preemption ruling a blow to plaintiffs  WASHINGTON – The U.S. Supreme Court’s decision barring state-law design-defect claims against generic drug makers that mirror failure-to-warn actions served...
3. Justices: Generic drug design-defect claims preempted  WASHINGTON — In a victory to generic pharmaceutical companies, the U.S. Supreme Court ruled today that state design-defect laws that...
4. Generic drug user can sue brand-name manufacturer  State law allows the user of a generic drug to sue the maker of the name-brand drug for fraudulent misrepresentation,...
5. Justices to rule on preemption of drug design defect claims  The U.S. Supreme Court has agreed to decide whether federal law preempts state law design defect claims targeting generic pharmaceutical...